| Source Date | Board Meeting Date | Details |
|
02-Sep-2025
|
08-Sep-2025
|
Inter alia, to consider and approve:- 1. To consider and approve the raising of funds by issuance of fully paid-up equity shares by way of rights issue to the existing eligible equity shareholders of the company and fix quantum of the issue as may be permitted under applicable law and subject to any regulatory/ statutory approvals, as may be required; 2. To constitute Rights Issue Committee as an analogous authority empowered to take necessary actions and to decide terms and conditions in the matter of rights issue of the Company; 3. To approve the objects of the Rights Issue.
|
|
28-Jul-2025
|
07-Aug-2025
|
Final Dividend & Quarterly Results
|
|
08-May-2025
|
16-May-2025
|
Audited Results
|
|
01-Apr-2025
|
09-Apr-2025
|
Inter alia, to consider and approve:- (1) To allot 1,20,06,831 (One Crore Twenty Lakhs Six Thousand Eight Hundred and Thirty One) fully convertible warrants to promoters/promoter group on private placement basis through preferential issue approved by the shareholders of the company in Extraordinary General Meeting (?EGM?) held on March 12, 2025 and as per the in-principle Approval letters dated March 28, 2025 received from BSE Limited and National Stock Exchange of India Ltd. for the same.
|
|
03-Feb-2025
|
11-Feb-2025
|
Quarterly Results & Preferential Issue of shares
|
|
03-Jan-2025
|
09-Jan-2025
|
Inter alia to consider the following matters:- 1. To consider and evaluate the raising of funds through issue of equity shares and/or any other eligible securities, including but not limited to warrants, depository receipts, FCCBs or any combination thereof or securities representing equity shares or convertible into or exchangeable for equity shares, through preferential issue, qualified institutions placement, further public offer, rights issue, debt issue, ADR, GDR, FCCB or such other permissible mode or combination thereof, as may be considered appropriate, subject to the approval of the members of the Company and other regulatory and/or statutory approvals, as applicable; 2. Any other business with the permission of the chair.
|
|
06-Nov-2024
|
14-Nov-2024
|
Quarterly Results
|
|
30-Jul-2024
|
13-Aug-2024
|
Quarterly Results
|
|
17-May-2024
|
27-May-2024
|
Right Issue of Equity Shares & Audited Results & Final Dividend
|
|
29-Feb-2024
|
05-Mar-2024
|
Increase in Authorised Capital
|